Summary
In the light of recent attempts to treat newly-diagnosed Type 1 (insulin-dependent) diabetic patients with cyclosporin A, and reports suggesting an impaired glucose tolerance following immunosuppresion therapy with cyclosporin A, we investigated the long-term effects of cyclosporin A on islet β-cell morphology and function in vitro. Collagenase-isolated mouse pancreatic islets were cultured free-floating for 7 days in medium RPMI 1640 + 10% calf serum in the presence of cyclosporin A (0.1 or 1.0 mg/l). Islets cultured in the presence of the higher cyclosporin A concentration had impaired islet proinsulin biosynthesis and insulin release when challenged with high glucose concentration. Moreover, the insulin content of the drug-exposed islets was decreased and so was the rate of DNA synthesis. The glucose oxidation and respiratory rates, however, remained unaffected, suggesting that the impaired insulin production was not a result of defective oxidative metabolism. There were no changes in the ultrastructure or phospholipid biosynthesis of the islets after the drug treatment. These data indicate that cyclosporin A affects islets in culture, the clinical implications of which are so far difficult to assess. The inhibitory effect of cyclosporin A on islet cell DNA synthesis must nevertheless be considered in attempts to ameliorate Type 1 (insulin-dependent) diabetes, and when grafting islet cells in numbers primarily insufficient to cure the recipient.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Merion RM, White DJG, Thiru S, Evans DB, Calne RY (1984) Cyclosporin: five years experience in cadaveric renal transplantation. N Engl J Med 310: 148–154
Rynaziewicz JJ, Sutherland DER, Ferguson RM, Squifflet JP, Morrow CE, Goetz FC, Najarian JS (1982) Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and human renal and pancreas transplantation. Diabetes 31 (suppl 4): 92–108
Nerup J, Lernmark Å (1981) Autoimmunity in insulin-dependent diabetes. Am J Med 70:135–141
Laupacis A, Gardell C, Dupre J, Stiller CR, Keown P, Wallace AC, Thibert P (1983) Cyclosporin prevents diabetes in BB Wistar rats. Lancet 1: 10–12
Gunnarsson R, Klintmalm G, Lundgren G, Wilczek H, Östman J Groth CG (1983) Deterioration in glucose metabolism in pancreatic transplant recipients. Lancet 2: 571–572
Howell SL, Taylor KW (1968) Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Biochem J 108: 17–24
Andersson A (1978) Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 14: 397–404
Heding LG (1972) Determination of total serum insulin in insulintreated patients. Diabetologia 8: 260–266
Berne C (1975) Anti-insulin serum coupled to Sepharose 4 B as a tool for the investigation of insulin biosynthesis in the B-cells of obese hyperglycemic mice. Endocrinology 97:1241–1247
Andersson A, Sandler S (1983) Viability tests of cryopreserved endocrine pancreatic cells. Cryobiology 20:161–168
Hellerström C (1967) Effects of carbohydrates on the oxygen consumption of isolated pancreatic islets of mice. Endocrinology 81: 105–112
Hallberg A, Berne C, Andersson A (1984) Effects of chloroquine on lipid metabolism of mouse pancreatic islets. Biochem Pharmacol (in press)
Swenne I, Bone AJ, Howell SL, Hellerström C (1980) Effects of glucose and amino acids on the biosynthesis of DNA and insulin in fetal rat islets maintained in tissue culture. Diabetes 29: 686–692
Swenne I (1982) The role of glucose in the in vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic B-cells. Diabetes 31: 754–760
Borg LAH, Andersson A (1981) Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations. Acta Diabetol Lat 18:65–83
Borel JF, Lafferty KJ (1983) Cyclosporin: speculation about its mechanism of action. Transplant Proc 15:1881–1885
Pozza G, Traeger J, Dubernard JM, Sechi A, Bosi E, Pontiroli A (1983) Cyclosporin and glucose tolerance in pancreas allotransplantation. Lancet 2:1080
Andersson A, Sandler S (1984) Culture and cryopreservation of isolated pancreatic islets. In: Andreani D, DiMario U, Federlin KF, Heding LG (eds) Immunology of diabetes. Kimpton Teviot Publications, London, pp 177–186
Andersson A (1975) Synthesis of DNA in isolated pancreatic islets maintained in tissue culture. Endocrinology 96: 1051–1054
Stiller CR, Laupacis A, Dupre J, Jenner MR, Known PA, Rodger PA, Wolff BMJ (1983) Cyclosporine for treatment of early Type I diabetes: preliminary results. N Engl J Med 308: 1226–1227
Groth CG, Andersson A, Björkén C, Gunnarsson R, Hellerström C, Lundgren G, Petersson B, Swenne I, Östman J (1980) Transplantation of fetal pancreatic microfragments via the portal vein to a diabetic patient. Diabetes 29 (Suppl 1): 80–83
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andersson, A., Borg, H., Hallberg, A. et al. Long-term effects of cyclosporin A on cultured mouse pancreatic islets. Diabetologia 27 (Suppl 1), 66–69 (1984). https://doi.org/10.1007/BF00275649
Issue Date:
DOI: https://doi.org/10.1007/BF00275649